Biologicals

Acellular pertussis vaccine

Pertussis, acellular component of monovalent or combined vaccines

Title: Guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines; Adopted 1996, TRS no 878, Annex 2

UPCOMING EVENTS


  • Working Group Meeting to develop WHO Guidelines on regulatory preparedness for vaccine non-producing countries in response to Pandemic Influenza emergency, 9-11 June 2015, Tunis Conference Centre, Tunisia

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971